Education

AbstractINTRODUCTIONWe investigated whether older adults with subjective memory complaints (SMC) and amyloid‐β accumulation may show clinical progression over 2…

AbstractAims: The role of sodium-glucose co-transporter 2 inhibitors (SGLT2i) in patients with cardiac amyloidosis (CA) is controversial. However, they have shown…

AbstractBackground: Amyloidosis is the extracellular accumulation of amyloid proteins in diverse organs. While ocular and periocular involvement is rare, it can be…

AbstractAmyloid light-chain (AL) amyloidosis, which results from monoclonal light-chain deposition from plasma cell dyscrasia, is often identified in old patients.…

AbstractBackground and AimsConcomitant aortic stenosis (AS) and transthyretin-associated cardiac amyloidosis (ATTR-CA) is an increasingly recognized cause of…

AbstractThe appearance of new treatments for the different forms of ATTR has highlighted the importance of early diagnosis, since most of these treatments are…

Background/Objectives: Cardiac amyloidosis (CA) is an underdiagnosed and potentially life-threatening infiltrative cardiomyopathy characterized by the extracellular…

AbstractOver 150 transthyretin (TTR) mutations have been identified in hereditary transthyretin (ATTRv) amyloidosis, and new TTR variants have recently emerged.…

Hereditary amyloid transthyretin variant (ATTRv) amyloidosis is a rare, life-threatening disease, characterized by the deposition of aggregated transthyretin (TTR)…

AbstractTransthyretin amyloid cardiomyopathy (ATTR-CM) is an infiltrative cardiomyopathy that results from myocardial deposition of misfolded transthyretin (TTR)…